Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin
Open Access
- 13 April 2018
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 33 (4) , 1211-1222
Abstract
Type 2 diabetes (T2DM) is associated with structural cortical and subcortical alterations, although it is insufficiently clear if these alterations are driven by obesity or by diabetes and its associated complications. We used FreeSurfer5.3 and FSL-FIRST to determine cortical thickness, volume and surface area, and subcortical gray matter volume in a group of 16 normoglycemic obese subjects and 28 obese T2DM patients without clinically manifest micro- and marcoangiopathy, and compared them to 31 lean normoglycemic controls. Forward regression analysis was used to determine demographic and clinical correlates of altered (sub)cortical structure. Exploratively, vertex-wise correlations between cortical structure and fasting glucose and insulin were calculated. Compared with controls, obese T2DM patients showed lower right insula thickness and lower left lateral occipital surface area (PFWE < 0.05). Normoglycemic obese versus controls had lower thickness (PFWE < 0.05) in the right insula and inferior frontal gyrus, and higher amygdala and thalamus volume. Thalamus volume and left paracentral surface area were also higher in this group compared with obese T2DM patients. Age, sex, BMI, fasting glucose, and cholesterol were related to these (sub)cortical alterations in the whole group (all P < 0.05). Insulin were related to temporal and frontal structural deficits (all PFWE < 0.05). Parietal/occipital structural deficits may constitute early T2DM-related cerebral alterations, whereas in normoglycemic obese subjects, regions involved in emotion, appetite, satiety regulation, and inhibition were affected. Central adiposity and elevated fasting glucose may constitute risk factors.Keywords
Funding Information
- Eli Lilly and Company
- Bristol-Myers Squibb (US)
- Novo Nordisk (DK)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR)
This publication has 39 references indexed in Scilit:
- Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer's DiseasePLOS Computational Biology, 2012
- Late-life obesity is associated with smaller global and regional gray matter volumes: a voxel-based morphometric studyInternational Journal of Obesity, 2012
- Increased amygdalar and hippocampal volumes in elderly obese individuals with or at risk of cardiovascular diseaseThe American Journal of Clinical Nutrition, 2011
- A Bayesian model of shape and appearance for subcortical brain segmentationNeuroImage, 2011
- Cognitive dysfunction in patients with type 2 diabetesDiabetes/Metabolism Research and Reviews, 2010
- Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognitionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Valid conjunction inference with the minimum statisticNeuroImage, 2005
- Advances in functional and structural MR image analysis and implementation as FSLNeuroImage, 2004
- Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain ImagesNeuroImage, 2002
- Cortical Surface-Based AnalysisNeuroImage, 1999